Yuexiang Wang
State Key Laboratory Of Drug Research
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Journal: Signal transduction and targeted therapy
Published: August 10, 2022
Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
Journal: Clinical and translational medicine
Published: January 10, 2022
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.
Journal: EBioMedicine
Published: October 13, 2021
Characterization of DNA damage response deficiency in pancreatic cancer patients from China.
Journal: Cancer communications (London, England)
Published: June 14, 2021
Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy.
Journal: Acta pharmaceutica Sinica. B
Published: May 25, 2021
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer.
Journal: Advanced biology
Published: September 30, 2019
Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer.
Journal: Cancer management and research
Published: December 23, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026